Accessibility Menu
 
Extendicare logo

Extendicare

(OTC) EXETF

Current Price$18.38
Market Cap$1.74B
Since IPO (2011)+567%
5 Year+304%
1 Year+108%
1 Month+3%

Extendicare Financials at a Glance

Market Cap

$1.74B

Revenue (TTM)

$1.66B

Net Income (TTM)

$96.64M

EPS (TTM)

$0.80

P/E Ratio

22.63

Dividend

$0.36

Beta (Volatility)

0.27 (Low)

Price

$18.38

Volume

1,841

Open

$18.36

Previous Close

$18.38

Daily Range

$18.28 - $18.38

52-Week Range

$8.62 - $20.78

EXETF News

EXETF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Extendicare

Industry

Healthcare Providers and Services

Employees

22,000

CEO

Michael R. Guerriere, PhD, MBA

Headquarters

Markham, ON L3R 4T9, CA

EXETF Financials

Key Financial Metrics (TTM)

Gross Margin

52%

Operating Margin

8%

Net Income Margin

6%

Return on Equity

39%

Return on Capital

19%

Return on Assets

9%

Earnings Yield

4.42%

Dividend Yield

0.02%

Payout Ratio

43.14%

Stock Overview

Market Cap

$1.74B

Shares Outstanding

94.46M

Volume

1.84K

Short Interest

0.00%

Avg. Volume

2.89K

Financials (TTM)

Gross Profit

$199.43M

Operating Income

$138.25M

EBITDA

$175.47M

Operating Cash Flow

$165.07M

Capital Expenditure

$101.73M

Free Cash Flow

$63.35M

Cash & ST Invst.

$348.90M

Total Debt

$342.65M

Extendicare Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$461.66M

+17.9%

Gross Profit

$55.34M

-85.9%

Gross Margin

11.99%

N/A

Market Cap

$1.74B

N/A

Market Cap/Employee

$73.88K

N/A

Employees

23,500

N/A

Net Income

$25.56M

+28.3%

EBITDA

$49.41M

+20.1%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$6.25M

+103.7%

Accounts Receivable

$85.11M

-7.8%

Inventory

$0.00

N/A

Long Term Debt

$322.82M

+23.5%

Short Term Debt

$19.83M

-36.2%

Return on Assets

9.06%

N/A

Return on Invested Capital

18.82%

N/A

Free Cash Flow

$31.40M

-869.3%

Operating Cash Flow

$30.73M

+75.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SAFLYSafilo Group S.p.A.
$4.00+0.00%
RKAGYRHON-KLINIKUM AG Unsponsored ADR
$8.16+0.00%
RHKJFRhoen-Klinikum AG
$15.30+0.00%
LTGHFLife Healthcare Group Holdings Limited
$0.68+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$10.31-0.03%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.31-0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$44.39+0.02%
UGROUrban-gro
$36.29+4.17%

Questions About EXETF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.